Cytokinetics (NASDAQ:CYTK) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Cytokinetics beat estimated earnings by 57.14%, reporting an EPS of $-0.36 versus an estimate of $-0.84.
Revenue was up $48.88 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.19 which was followed by a 6.27% increase in the share price the next day.
Here's a look at Cytokinetics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.76 | -0.65 | -0.58 | |
| EPS Actual | -0.95 | -0.86 | -0.66 | -0.62 |
| Revenue Estimate | 6.42M | 5.45M | 6.58M | 8.56M |
| Revenue Actual | 5.44M | 2.84M | 6.55M | 6.72M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
